XTL BIOPHARMACEUTICALS LTD. Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of -$712.00 thousand for the 6-month period ending 2021-06-30, per its 6-K filed 2021-08-24.
Discontinued › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2021-08-24
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|---|
| 2021-06-30 | -$712.00K 6-K · filed 2021-08-24 | |
| 2020-12-31 | -$818.00K 20-F/A · filed 2021-05-19 | |
| 2020-06-30 | -$427.00K 6-K · filed 2021-08-24 | |
| 2019-12-31 | $1.20M 20-F/A · filed 2021-05-19 | |
| 2018-12-31 | -$38.00K 20-F/A · filed 2021-05-19 | |
| 2017-12-31 | $1.27M 20-F · filed 2020-03-12 | |
| 2016-12-31 | -$1.80M 20-F · filed 2019-03-11 | |
| 2015-12-31 | $1.61M 20-F · filed 2018-03-15 |